Products
| Product Name | CAS No. | Specification | Application | Registration |
| Tenofovir Alafenamide Hemifumarate | 1392275-56-7 | 99+% | ||
| Tenofovir Disoproxil Fumarate | 202138-50-9 | 98+% | ||
| Tadalafil | 171596-29-5 | 99+% | ||
| Tobramycin | 32986-56-4 | 900μg/mg+ | ||
| Tobramycin Sulfate | 79645-27-5 | 634 to 739μg/mg | ||
| Temozolomide | 85622-93-1 | 98+% | ||
| Temsirolimus (CCI-779) | 162635-04-3 | 98+% | mTOR inhibitor | Autophagy activator | Apoptosis related activator | |
| Temoporfin (KW2345) | 122341-38-2 | 95+% | ||
| Trastuzumab (anti-HER2) | 180288-69-1 | 95+% | EGFR | ADC Antibody |Antineoplastic Agent |the treatment of HER2 receptor positive breast cancer | |
| Tofacitinib Citrate | 540737-29-9 | 98+% | rheumatoid arthritis | Janus Kinase Inhibitors | |
| Tofacitinib (CP-690550) | 477600-75-2 | 98+% | rheumatoid arthritis | JAK inhibitor | |
| tert-Butyl [(1S,2R)-1-benzyl-2-hydroxy-3-(isobutylamino)propyl]carbamate | 160232-08-6 | 98+% |
Products
Custom Synthesis-High Value-Added Advanced Pharmaceutical Intermediates
E-Mail: sales (at)Chemleader.com.cn
E-Mail: sales (at)Chemleader.com.cn